131 related articles for article (PubMed ID: 9016310)
1. Immunocytochemical phenotyping of disseminated tumor cells in bone marrow by uPA receptor and CK18: investigation of sensitivity and specificity of an immunogold/alkaline phosphatase double staining protocol.
Allgayer H; Heiss MM; Riesenberg R; Babic R; Jauch KW; Schildberg FW
J Histochem Cytochem; 1997 Feb; 45(2):203-12. PubMed ID: 9016310
[TBL] [Abstract][Full Text] [Related]
2. Urokinase plasminogen activator receptor (uPA-R): one potential characteristic of metastatic phenotypes in minimal residual tumor disease.
Allgayer H; Heiss MM; Riesenberg R; Grützner KU; Tarabichi A; Babic R; Schildberg FW
Cancer Res; 1997 Apr; 57(7):1394-9. PubMed ID: 9102229
[TBL] [Abstract][Full Text] [Related]
3. Minimal residual disease in gastric cancer: evidence of an independent prognostic relevance of urokinase receptor expression by disseminated tumor cells in the bone marrow.
Heiss MM; Simon EH; Beyer BC; Gruetzner KU; Tarabichi A; Babic R; Schildberg FW; Allgayer H
J Clin Oncol; 2002 Apr; 20(8):2005-16. PubMed ID: 11956259
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of extended biologic staging by bone marrow micrometastases and tumor-associated proteases in gastric cancer.
Heiss MM; Allgayer H; Gruetzner KU; Babic R; Jauch KW; Schildberg FW
Ann Surg; 1997 Dec; 226(6):736-44; discussion 744-5. PubMed ID: 9409572
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical detection and phenotypic characterization of micrometastatic tumour cells in bone marrow of patients with prostate cancer.
Oberneder R; Riesenberg R; Kriegmair M; Bitzer U; Klammert R; Schneede P; Hofstetter A; Riethmüller G; Pantel K
Urol Res; 1994; 22(1):3-8. PubMed ID: 7521088
[TBL] [Abstract][Full Text] [Related]
6. CD87-positive tumor cells in bone marrow aspirates identified by confocal laser scanning fluorescence microscopy.
Noack F; Helmecke D; Rosenberg R; Thorban S; Nekarda H; Fink U; Lewald J; Stich M; Schutze K; Harbeck N; Magdolen V; Graeff H; Schmitt M
Int J Oncol; 1999 Oct; 15(4):617-23. PubMed ID: 10493940
[TBL] [Abstract][Full Text] [Related]
7. Urokinase-like plasminogen activator receptor expression on disseminated breast cancer cells.
Tögel F; Datta C; Badbaran A; Kröger N; Renges H; Gieseking F; Jänicke F; Zander AR; Krüger W
J Hematother Stem Cell Res; 2001 Feb; 10(1):141-5. PubMed ID: 11276367
[TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical double staining of cytokeratin and prostate specific antigen in individual prostatic tumour cells.
Riesenberg R; Oberneder R; Kriegmair M; Epp M; Bitzer U; Hofstetter A; Braun S; Riethmüller G; Pantel K
Histochemistry; 1993 Jan; 99(1):61-6. PubMed ID: 7682210
[TBL] [Abstract][Full Text] [Related]
9. Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase.
Borgen E; Beiske K; Trachsel S; Nesland JM; Kvalheim G; Herstad TK; Schlichting E; Qvist H; Naume B
J Pathol; 1998 Aug; 185(4):427-34. PubMed ID: 9828843
[TBL] [Abstract][Full Text] [Related]
10. A new approach to phenotyping disseminated tumor cells: methodological advances and clinical implications.
Noack F; Schmitt M; Bauer J; Helmecke D; Krüger W; Thorban S; Sandherr M; Kuhn W; Graeff H; Harbeck N
Int J Biol Markers; 2000; 15(1):100-4. PubMed ID: 10763150
[TBL] [Abstract][Full Text] [Related]
11. Urokinase-plasminogen-activator receptor expression in disseminated tumour cells in the bone marrow and peripheral blood of patients with clinically localized prostate cancer.
Thomas C; Wiesner C; Melchior SW; Schmidt F; Gillitzer R; Thüroff JW; Pfitzenmaier J
BJU Int; 2009 Jul; 104(1):29-34. PubMed ID: 19154451
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system.
Heiss MM; Babic R; Allgayer H; Gruetzner KU; Jauch KW; Loehrs U; Schildberg FW
J Clin Oncol; 1995 Aug; 13(8):2084-93. PubMed ID: 7636552
[TBL] [Abstract][Full Text] [Related]
13. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow.
Pantel K; Schlimok G; Angstwurm M; Weckermann D; Schmaus W; Gath H; Passlick B; Izbicki JR; Riethmüller G
J Hematother; 1994; 3(3):165-73. PubMed ID: 7530132
[TBL] [Abstract][Full Text] [Related]
14. The urokinase-receptor (CD87) is expressed in cells of the megakaryoblastic lineage.
Wohn KD; Kanse SM; Deutsch V; Schmidt T; Eldor A; Preissner KT
Thromb Haemost; 1997 Mar; 77(3):540-7. PubMed ID: 9066008
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells.
Pantel K; Schlimok G; Braun S; Kutter D; Lindemann F; Schaller G; Funke I; Izbicki JR; Riethmüller G
J Natl Cancer Inst; 1993 Sep; 85(17):1419-24. PubMed ID: 7688814
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of urokinase-type plasminogen activator (uPA), its receptor (uPA-R), and inhibitor type-2 (PAI-2) during differentiation of keratinocytes in an organotypic coculture system.
Schaefer BM; Stark HJ; Fusenig NE; Todd RF; Kramer MD
Exp Cell Res; 1995 Oct; 220(2):415-23. PubMed ID: 7556451
[TBL] [Abstract][Full Text] [Related]
17. Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies.
Carriero MV; Franco P; Del Vecchio S; Massa O; Botti G; D'Aiuto G; Stoppelli MP; Salvatore M
Cancer Res; 1994 Oct; 54(20):5445-54. PubMed ID: 7923178
[TBL] [Abstract][Full Text] [Related]
18. Disseminated tumor cells in bone marrow of patients with transitional cell carcinoma: immunocytochemical detection and correlation with established prognostic indicators.
Hofmann T; Riesenberg R; Buchner A; Zimmermann W; Hofstetter A; Oberneder R
J Urol; 2003 Apr; 169(4):1303-7. PubMed ID: 12629348
[TBL] [Abstract][Full Text] [Related]
19. Frequency and prognostic relevance of disseminated tumor cells in bone marrow of patients with metastatic renal cell carcinoma.
Buchner A; Riesenberg R; Kotter I; Hofstetter A; Stief C; Oberneder R
Cancer; 2006 Apr; 106(7):1514-20. PubMed ID: 16518813
[TBL] [Abstract][Full Text] [Related]
20. Detection and prognostic value of cytokeratin positive tumor cells in bone marrow of patients with renal cell carcinoma.
Buchner A; Riesenberg R; Kotter I; Crispin A; Hofstetter A; Oberneder R
J Urol; 2003 Nov; 170(5):1747-51. PubMed ID: 14532768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
